E1	Condition:T1 Name:T2
E3	Condition:T3 Name:T4
E5	Condition:T5 Name:T6
E7	Condition:T7 Name:T8
E9	Condition:T9 Name:T10
E11	Condition:T11 Name:T12 Minimum-Count:E18
E13	Condition:T13 Name:T14
E15	Condition:T15 Name:T16
E17	Drug:T17 Name:T18
E18	Eq-Comparison:T26 Operator:T19 Value:T22
E19	Eq-Comparison:T27 Operator:T20 Temporal-Unit:T21 Value:T25
E2	Condition:T28 Name:T29
E4	Modifier:T30 Modifies:T29
E6	And:T31 Arg:E1 Arg2:E2
E8	Condition:T32 Name:T33
E10	Condition:T34 Name:T35
E12	Or:T36 Arg:E10 Arg2:E15
E14	Assertion:T37 Asserted:E11
E16	Condition:T38 Name:T39
E20	Or:T40 Arg:E13 Arg2:E16
E21	Condition:T41 Name:T42
E22	Assertion:T43 Asserted:E21
E23	Condition:T44 Name:T45
E24	Condition:T46 Name:T47
E25	Or:T48 Arg:E5 Arg2:E23
E26	Or:T49 Arg:E23 Arg2:E24
E27	Modifier:T50 Modifies:E7
E28	Condition:T51 Name:T52
E29	Modifier:T53 Modifies:T52
E30	Condition:T54 Name:T55
E31	Condition:T56 Name:T57
E32	Or:T58 Arg:E30 Arg2:E31
E33	Eq-Comparison:T24 Temporal-Period:T59
E34	Drug:T60 Name:T61
E35	Procedure:T62 Temporality:E33
E36	Other:T63 Is-Other:E17
E37	Drug:T64 Name:T65
E38	Or:T66 Arg:E17 Arg2:E37
E39	Condition:T67 Name:T68
E40	Condition:T69 Name:T70
E41	Or:T71 Arg:E39 Arg2:E40
E42	Condition:T73 Name:T74 Severity:T75
E43	Observation:T76 Name:T77 Eq-Comparison:E19
T1	Condition 91 89	CAPS
T2	Condition-Name 91 89	CAPS
T3	Condition 413 377	Sensorineural hearing loss
T4	Condition-Name 413 377	Sensorineural hearing loss
T5	Condition 469 430	arthralgia
T6	Condition-Name 469 430	arthralgia
T7	Condition 539 492	aseptic meningitis
T8	Condition-Name 539 492	aseptic meningitis
T9	Condition 317 287	Urticaria-like rash
T10	Condition-Name 317 287	Urticaria-like rash
T11	Condition 250 228	CAPS
T12	Condition-Name 250 228	CAPS
T13	Condition 340 308	Cold
T14	Condition-Name 340 308	Cold
T15	Condition 196 183	SAA
T16	Condition-Name 196 183	SAA
T17	Drug 802 736	biological agents
T18	Drug-Name 802 736	biological agents
T19	Eq-Operator 236 217	≥
T20	Eq-Operator 940 869	less than
T21	Eq-Temporal-Unit 950 878	months
T22	Eq-Value 239 218	2
T23	Eq-Value 245 223	6
T25	Eq-Value 943 871	6
T26	Eq-Comparison 239 218	≥2
T27	Eq-Comparison 950 878	less than 6 months
T28	Condition 126 121	pathogenic mutation(s)
T29	Condition-Name 126 121	pathogenic mutation(s)
T30	Modifier 141 135	NLRP3 gene
T31	And 95 93	and
T32	Condition 184 174	Raised inflammatory markers
T33	Condition-Name 184 174	Raised inflammatory markers
T34	Condition 190 179	CRP
T35	Condition-Name 190 179	CRP
T36	Or 192 180	/
T37	Assertion 275 251	symptoms
T38	Condition 349 315	stress
T39	Condition-Name 349 315	stress
T40	Or 342 309	/
T41	Condition 447 409	Musculoskeletal
T42	Condition-Name 447 409	Musculoskeletal
T43	Assertion 456 418	symptoms
T44	Condition 481 440	arthritis
T45	Condition-Name 481 440	arthritis
T46	Condition 491 448	myalgia
T47	Condition-Name 491 448	myalgia
T48	Or 471 431	/
T49	Or 483 441	/
T50	Modifier 520 473	Chronic
T51	Condition 580 531	abnormalities
T52	Condition-Name 580 531	abnormalities
T53	Modifier 566 517	Skeletal
T54	Condition 604 554	epiphyseal overgrowth
T55	Condition-Name 604 554	epiphyseal overgrowth
T56	Condition 622 570	frontal bossing
T57	Condition-Name 622 570	frontal bossing
T58	Or 606 555	/
T24	Eq-Comparison 745 683	Being
T59	Eq-Temporal-Period 745 683	Being
T60	Drug 776 711	IL-1 inhibitor
T61	Drug-Name 776 711	IL-1 inhibitor
T62	Procedure 753 691	treated
T63	Other 784 718	other
T64	Drug 825 759	immunosuppressants
T65	Drug-Name 825 759	immunosuppressants
T66	Or 806 740	and
T67	Condition 846 778	Pregnant
T68	Condition-Name 846 778	Pregnant
T69	Condition 860 792	lactating
T70	Condition-Name 860 792	lactating
T71	Or 850 782	and
T72	Life-Stage-And-Gender 866 798	women
T73	Condition 909 839	organ function failure
T74	Condition-Name 909 839	organ function failure
T75	Severity 886 816	Serious
T76	Observation 930 859	expected life time
T77	Observation-Name 930 859	expected life time
A1	Eq-Operator-Value T19 GTEQ
A2	Eq-Operator-Value T20 LT
A3	Eq-Temporal-Unit-Value T21 month
A4	Assertion-Type-Value E14 possible
A5	Assertion-Type-Value E22 possible
A6	Eq-Temporal-Period-Value T59 present
A7	Life-Stage-And-Gender-Type T72 female
A8	Severity-Value T75 severe
R1	Example-Of Arg1:E10 Arg2:E8
R2	Example-Of Arg1:E15 Arg2:E8
R3	Example-Of Arg1:E5 Arg2:E21
R4	Example-Of Arg1:E23 Arg2:E21
R5	Example-Of Arg1:E24 Arg2:E21
R6	Example-Of Arg1:E30 Arg2:E28
R7	Example-Of Arg1:E31 Arg2:E28
R8	Using Arg1:E35 Arg2:E34
R9	If-Then Arg1:T72 Arg2:E40